CareTrust REIT (CTRE) Q1 2026 earnings review
Record Investments Drive Top-Line Surge, But Equity Issuance Dilutes the Bottom Line
CareTrust REIT is executing its external growth strategy at breakneck speed. Total revenues skyrocketed 48% YoY to $142.8M, fueled by a relentless acquisition pipeline, including an $864.1M post-quarter closing spree. Management is operating with a fortress balance sheet—Net Debt to EBITDA sits at an incredibly low 0.6x, allowing them to remain aggressive. However, this growth has a cost: the company issued a massive amount of stock via its ATM program to fund these deals, inflating the diluted share count by 20% YoY. Consequently, while absolute Normalized FFO surged 38%, Normalized FFO per share grew by a more modest 14%. Ultimately, the sheer volume of 8.8%-8.9% yielding acquisitions makes this a highly accretive quarter, prompting a raised FY26 guidance.
🐂 Bull Case
The company closed $245M in Q1 and an astonishing $864M in April at an 8.9% blended yield, drastically accelerating the revenue base without over-leveraging.
Net Debt to EBITDA of 0.6x is virtually unheard of in the REIT space, providing unparalleled dry powder for future M&A without relying on expensive debt.
🐻 Bear Case
To maintain low leverage, CTRE heavily utilized its ATM program. A 20% YoY increase in share count significantly dampens the per-share translation of their massive portfolio expansion.
The new Senior Housing Operating (SHOP) segment reported $3.85M in revenue against $3.1M in operating expenses. Unlike their triple-net core, this introduces severe operating leverage risks and tight margins.
⚖️ Verdict: 🟢
Bullish. While the equity dilution is heavy, it is being immediately deployed into highly accretive, high-yield acquisitions. The raised FY26 guidance and pristine balance sheet prove the strategy is working.
Key Themes
Aggressive Capital Deployment
Accelerating. CareTrust's acquisition engine is running hot. Q1 saw $245.1M in closed investments at an 8.8% yield, followed immediately by $864.1M post-quarter at an 8.9% yield. The company's ability to source deals at near 9% stabilized yields is the primary driver of their 14% YoY growth in Normalized FFO per share.
Balance Sheet Flexibility
Stable. The company is operating with extreme financial conservatism. Net Debt to Annualized Normalized Run Rate EBITDA is 0.6x, vastly below management's target range of 4.0x to 5.0x. This is driven by aggressive ATM equity issuance ($129.5M in Q1, $363.6M settled post-quarter), keeping the $1.2B revolver mostly undrawn and enabling rapid transaction execution.
Skilled Nursing Core Rent Growth
Accelerating. Skilled Nursing Triple-Net revenue surged from $62.1M in 25Q1 to $81.1M in 26Q1 (+30% YoY). This segment remains the cash-generating bedrock of the company, boasting 100% rent and interest collection and strong EBITDAR coverage ratios (2.52x).
Data Science Platform Upgrades
Stable. Management has been actively investing in data science and analytics talent. This technology infrastructure investment was initially designed to support the rollout of the new SHOP portfolio but is increasingly being leveraged to improve underwriting speed and precision across the broader triple-net SNF pipeline.
Massive Shareholder Dilution Contradicts 'Firing on All Cylinders' Narrative
Decelerating per-share leverage. Management touts explosive top-line and EBITDA growth, but a key data point contradicts the euphoria: the weighted average diluted share count spiked from 187.4 million in 25Q1 to 224.0 million in 26Q1 (+20%). Consequently, while absolute Normalized FFO grew by an impressive 38% YoY ($77.8M to $107.4M), the per-share FFO grew by only 14%. Shareholders are absorbing significant dilution to fund this growth.
SHOP Transition Creates Margin Drag
Reversing. CareTrust's foray into the Seniors Housing Operating Portfolio (SHOP) model marks a departure from its high-margin triple-net roots. In Q1 26, the company recorded $3.85M in resident fees but $3.1M in senior housing operating expenses. This translates to an ~80% operating ratio, exposing the REIT to wage inflation and occupancy risks that their traditional NNN leases completely avoided.
Yield Compression and Competition
Stable. Despite maintaining high acquisition yields (8.8%-8.9%), management previously noted intense competition and cap rate compression in the Seniors Housing space. As CTRE pushes further into SHOP and Seniors Housing, maintaining these high unlevered returns will become increasingly difficult against private equity buyers.
Macro: Locked-In Rent Escalators
Stable. Guidance is anchored on 2.5% inflation-based rent escalators under long-term triple-net leases. While this provides a predictable cash flow floor, it also acts as a cap. If macro inflation re-accelerates past 2.5%, the company's triple-net rental income growth will trail real-world costs, emphasizing the strategic importance of the new (though riskier) SHOP operating segment to capture macro upside.
Other KPIs
Accelerating. Up 59% YoY from $71.6M in 25Q1. This massive jump reflects the absorption of record 2025 and early 2026 acquisitions into the rent roll. The growth is heavily weighted toward Senior Housing Triple-net, which surged 249% YoY to $33.1M.
Decelerating sequential growth, but up 68% YoY. Interest expense has plateaued over the last three quarters ($12.6M -> $11.3M -> $11.2M) as the company aggressively prioritized equity financing via its ATM program over drawing down its revolver.
Guidance
Accelerating. The midpoint of $2.02 represents a 14.8% increase over FY25 results. This is highly impressive given that guidance assumes NO new investments beyond those made year-to-date, meaning the current $360M pipeline represents pure upside to this figure.
Accelerating. The midpoint of $2.00 represents a 13.6% increase over FY25. The payout ratio remains highly conservative at roughly 81%, easily supporting the recent 16.4% dividend hike to $0.39 per quarter.
Accelerating. Reflects strong bottom-line growth even factoring in depreciation and amortization from the massively expanded real estate portfolio.
Key Questions
SHOP Margin Trajectory
With Q1 resident fees of $3.85M and operating expenses of $3.1M, early SHOP operating margins are tight. What is the stabilized margin target for the SHOP portfolio, and how long will it take to get there?
Target Leverage Strategy
Net Debt to EBITDA is sitting at 0.6x, dramatically below the target range of 4.0x to 5.0x. Is this an intentional strategy to keep dry powder for a massive portfolio acquisition, or simply a reflection of highly favorable equity pricing through the ATM?
UK Portfolio Integration
The Care REIT acquisition was a major strategic pivot in 2025. How is the UK pipeline developing relative to management's initial expectations, and are yields holding up post-integration?
Limits to ATM Issuance
Given the 20% YoY increase in share count, is there an internal threshold where management believes equity dilution outweighs the accretion of 8.9% yielding acquisitions?